Testing effectiveness (Phase 2)UnknownNCT03805399What this trial is testingFUSCC Refractory TNBC Umbrella (FUTURE)Who this might be right forTriple-negative Breast Cancer Fudan University 140
Early research (Phase 1)Study completedNCT03205176What this trial is testingAZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasWho this might be right forMalignant Solid TumorsLymphomaOvarian Cancer+3 more AstraZeneca 49
Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT04216472What this trial is testingNab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN AlterationsWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more M.D. Anderson Cancer Center 6
Early research (Phase 1)Study completedNCT01837095What this trial is testingDose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Polyphor Ltd. 54
Early research (Phase 1)Looking for participantsNCT06577987What this trial is testingSafety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesWho this might be right forAdvanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more Circle Pharma 220
Early research (Phase 1)Study completedNCT01495663What this trial is testingDose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedWho this might be right forCancer Cellectar Biosciences, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04837209What this trial is testingRadiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast CancerWho this might be right forBreast CancerTriple Negative Breast Cancer Massachusetts General Hospital 32
Early research (Phase 1)Study completedNCT02898207What this trial is testingOlaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast CancerWho this might be right forMetastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more National Cancer Institute (NCI) 28
Early research (Phase 1)Study completedNCT01391143What this trial is testingSafety Study of MGA271 in Refractory CancerWho this might be right forProstate CancerMelanomaRenal Cell Carcinoma+4 more MacroGenics 179
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Early research (Phase 1)Looking for participantsNCT05768932What this trial is testingBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdvanced Solid TumorTNBC - Triple-Negative Breast CancerGastric Cancer+1 more SillaJen, Inc. 260
Testing effectiveness (Phase 2)UnknownNCT02839954What this trial is testingCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Study completedNCT01520389What this trial is testingSafety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentWho this might be right forAdvanced Solid TumorsColorectal CancerSquamous Cell Head and Neck Cancer+2 more Merrimack Pharmaceuticals 112
Testing effectiveness (Phase 2)Ended earlyNCT01698281What this trial is testingPhase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast CancerWho this might be right forBreast Cancer AEterna Zentaris 7
Testing effectiveness (Phase 2)UnknownNCT02587689What this trial is testingPhase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+1 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05741164What this trial is testingPropranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+2 more Emory University 37
Early research (Phase 1)Study completedNCT00892736What this trial is testingVeliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyWho this might be right forBasal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)Study completedNCT02574455What this trial is testingTrial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forBreast Cancer Gilead Sciences 529